Comments
Shares of the API manufacturer Lasa Supergenerics gained as much as 8.6 per cent to ₹78 after it announced getting an ex parte interim relief from commercial division of the Bombay High Court.
The relief granted would protect and strengthen its research and confidential information and its position in the 'Benzimidazole derivates' market, it said in a stock exchange communication.
The relief would also prevent the misuse of proprietary rights and will act as a deterrent to infringers, it further added.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.